1997
DOI: 10.1128/aac.41.5.1010
|View full text |Cite
|
Sign up to set email alerts
|

Antibacterial activity of BMS-180680, a new catechol-containing monobactam

Abstract: The in vitro activities of a new catechol-containing monobactam, BMS-180680 (SQ 84,100), were compared to those of aztreonam, ceftazidime, imipenem, piperacillin-tazobactam, ciprofloxacin, amikacin, and trimethoprim-sulfamethoxazole. BMS-180680 was often the most active compound against many species of the family Enterobacteriaceae, with MICs at which 90% of the isolates were inhibited (MIC90s) of < or = 0.5 microg/ml for Escherichia coli, Klebsiella spp., Citrobacter diversus, Enterobacter aerogenes, Serra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
19
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(19 citation statements)
references
References 25 publications
0
19
0
Order By: Relevance
“…The researchers from Bristol Myers Squibb described the in vitro activity of monobactam derivative 164 , containing a catechol analogue, 6,7‐dihydroxyquinoxaline, directly attached to the oxime side chain at position 3 of the β‐lactam ring (BMS‐180680 164 ; Fig. ) . This structural feature enabled the compound to utilize the Cir and Fiu iron‐regulated outer membrane receptor proteins and the TonB‐dependent iron transport system for enhanced uptake across the bacterial outer membrane.…”
Section: Siderophore‐conjugated Monocyclic β‐Lactamsmentioning
confidence: 99%
“…The researchers from Bristol Myers Squibb described the in vitro activity of monobactam derivative 164 , containing a catechol analogue, 6,7‐dihydroxyquinoxaline, directly attached to the oxime side chain at position 3 of the β‐lactam ring (BMS‐180680 164 ; Fig. ) . This structural feature enabled the compound to utilize the Cir and Fiu iron‐regulated outer membrane receptor proteins and the TonB‐dependent iron transport system for enhanced uptake across the bacterial outer membrane.…”
Section: Siderophore‐conjugated Monocyclic β‐Lactamsmentioning
confidence: 99%
“…Catecholate and hydroxamate conjugates of oxamazin‐type monocyclic β‐lactams have been investigated but were found to promote growth through their siderophore activity, rather than inhibit it through their antibiotic activity 56,57,66 . Catecholate monobactams were explored at Bristol‐Myers Squibb, giving rise to BMS‐180680, which showed a spectrum like aztreonam, with some enhancement of activity against P. aeruginosa and S. maltophilia 67 . Like other catecholate conjugates, BMS‐180680 showed elevated MICs for E. coli strains with defects in TonB and Cir/Fiu double mutations 67 .…”
Section: Synthetic Conjugates Between Siderophores and β‐Lactam Antibmentioning
confidence: 99%
“…Catecholate monobactams were explored at Bristol‐Myers Squibb, giving rise to BMS‐180680, which showed a spectrum like aztreonam, with some enhancement of activity against P. aeruginosa and S. maltophilia 67 . Like other catecholate conjugates, BMS‐180680 showed elevated MICs for E. coli strains with defects in TonB and Cir/Fiu double mutations 67 . Siderophore monobactams in which a hydroxypyridone moiety is carried on the oxyaminoacylamino side were pursued by the Takeda and Synphar companies, giving rise to PTX 2416 ( 43 ) 68,69 .…”
Section: Synthetic Conjugates Between Siderophores and β‐Lactam Antibmentioning
confidence: 99%
“…Moreover, most of compounds incorporating catechol moiety exhibit antioxidant, 1 anticarcinogenic, 2,3 antifungous, 4 and antibacterial activities 5,6 or are used as HIV integrase inhibitors. 7e9 For example, dopamine is a neurotransmitter in the central nervous system of human and other vertebrate animals, 10 whereas, dicaffeoyltartaric acid 7 and dicaffeoylquinic acid 7,8 …”
Section: Introductionmentioning
confidence: 99%